NVRL has just been notified of manufacturer supply issues with the BioMerieux Vidas HEV IgM assay. Due to factors beyond our control the implementation of the Liaison HEV IgM assay and supplementary second line Vidas HEV IgM will be delayed. We will issue further updates as available.
CN-22-20
